Does Statin Use in Frail Patients Provide Survival Benefits? Insights From a Meta-Analysis.

[1]  M. Kivimäki,et al.  Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort. , 2019, Age and ageing.

[2]  John Fuller,et al.  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials , 2019, The Lancet.

[3]  C. Bell,et al.  One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins , 2019, Canadian Medical Association Journal.

[4]  M. Brookhart,et al.  Selective prescribing of statins and the risk of mortality, hospitalizations, and falls in aged care services. , 2018, Journal of clinical lipidology.

[5]  L. Ferrucci,et al.  Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease. , 2016, The American journal of cardiology.

[6]  D. Melzer,et al.  Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  L. Green,et al.  Statin Use in Very Elderly Individuals, 1999-2012. , 2015, JAMA internal medicine.

[8]  K. Johnell,et al.  Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates. , 2015, British journal of clinical pharmacology.

[9]  J. Fleg,et al.  Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. , 2013, Circulation.

[10]  T. Travison,et al.  Statin use and clinical outcomes in older men: a prospective population-based study , 2013, BMJ Open.

[11]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[12]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.